CFHR5 and glomerular disorder: FHR-1 and FHR-5 have been linked to glomerular diseases, where pathogenic, gain-of-function variants cause enhanced complement activation (34, 38, 39, 48) [for more details on disease associations see (43)], and the presence of these proteins at sites of tissue damage has been detected (62, 63).